Video: Who Am I?| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Lupus Nephritis
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • Technology
      • Information Technology
      • Apps
    • QA/QI
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
      • Education & Training
    • Certification
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Search results for: health insurance

Opioid Painkiller Prescriptions May Run in Families

Lisa Rapaport  |  December 12, 2017

(Reuters Health)—When one person in a household gets prescribed opioids, the other people who live with them are more likely to get their own prescriptions for these narcotic painkillers, a U.S. study suggests. Researchers examined data on about 12.6 million people living in a household where someone was prescribed opioids and 6.4 million individuals in…

Filed under:AnalgesicsDrug Updates Tagged with:familyOpioid abuseopioid painkillersOpioids

Biosimilars Great Debate: To Switch or Not?

Susan Bernstein  |  November 17, 2017

SAN DIEGO—Should patients with rheumatic diseases switch from a biologic to its biosimilar? At the 2017 ACR/ARHP Annual Meeting’s Great Debate, held Nov. 5, two rheumatologists argued whether to switch or stay put based on safety, efficacy and potential cost savings. First to the podium to make the case for switching, Jonathan Kay, MD, tweaked…

Filed under:Biologics/DMARDsEducation & TrainingMeeting Reports Tagged with:2017 ACR/ARHP Annual MeetingBiologicsBiosimilarsJonathan KayRheumatic DiseaseRoy Fleischmann

Lower Medicaid Fees Linked to Scarcer Primary Care Appointments

Cheryl Platzman Weinstock  |  November 16, 2017

(Reuters Health)—When the fees paid to healthcare providers by Medicaid go up, appointments with primary care doctors suddenly become more available to Medicaid beneficiaries – and the opposite happens when fees go down, according to a recent U.S. study. Researchers found that, overall, every $10 change up or down in the Medicaid fees paid to…

Filed under:Practice SupportProfessional Topics Tagged with:lower Medicaid feesMedicaid funding reductionsprimary care appointmentsU.S. study

Consumers Sign Up for Obamacare 2018 Individual Plans Despite Uncertainty

Reuters Staff  |  November 9, 2017

NEW YORK (Reuters)— Consumer sign-ups for Obamacare individual insurance plans were more than 600,000 during the first week of enrollment for 2018, a U.S. health agency said on Thursday, a positive sign for insurers who take part in the healthcare program that Republicans are trying to undo. The Centers for Medicare & Medicaid Services, a…

Filed under:Legislation & AdvocacyProfessional Topics Tagged with:consumer sign-upsObamacare 2018 individual plans

Amid Trump Cuts, Uber Kicks Off Campaign to Enroll Drivers in Obamacare

Salvador Rodriguez  |  November 9, 2017

SAN FRANCISCO (Reuters)—Uber Technologies Inc and some smaller technology companies are launching campaigns to publicize Obamacare enrollment among their contract workers after the Trump administration slashed government marketing for the health program by 90 percent. Freelance and contract workers are an important part of the workforce for many Silicon Valley companies, including drivers at Uber…

Filed under:Legislation & AdvocacyProfessional Topics Tagged with:Obamacare enrollment campaignUber Technologies Inc

AndreyCherkasov / Shutterstock.com

Rheumatic Disease Does Not Preclude Pregnancy

Ruth Jessen Hickman, MD  |  November 9, 2017

Preconception planning is essential to help women with autoimmune disease have optimal pregnancy outcomes. Unplanned pregnancy can also negatively impact disease course in some patients. Yet many rheumatologic patients of childbearing age do not receive adequate contraception or prepregnancy education and counseling. Rheumatologists must work collaboratively with other healthcare providers to make sure rheumatic patients…

Filed under:Conditions Tagged with:Autoimmune diseasecontraceptivecounselingEducationInflammatory MyopathiesLupusoutcomepatient carepregnancyRheumatic DiseaseRheumatoid arthritisrheumatologistriskSystemic sclerosisVasculitisWomen

Year in Review: The ACR Advances Education, Rheumatic Disease Awareness, Strategic Planning in 2017

Sharad Lakhanpal, MBBS, MD  |  November 5, 2017

It seems like yesterday I was asked to write my first presidential column, and here I am penning my last. It’s incredible how fast the time goes and yet how much gets done. That progress is made possible by the dedicated and talented group of ACR volunteers and staff. This year, the College has had…

Filed under:Patient PerspectiveResearch RheumWorkforce Tagged with:AC&RAffordable Care Act (ACA)American College of Rheumatology (ACR)AwarenessCDCCommittee on Rheumatologic Care (CORC)DatabasedrugEducationFDAgoalmissionResearchRheumatic DiseaserheumatologistRISETraining

Unwise Choices: EHRs, PBMs, Drug Costs Are Leading to Physician Burnout

Simon M. Helfgott, MD  |  November 5, 2017

My dear electronic health records How do I dislike thee? Let me count the ways Adaptation of Sonnet 43 By Elizabeth Barrett Browning, 1806–1861 As my tenure as physician editor winds down, it’s worth reviewing some of the more nettlesome issues confronting clinicians that have been previously discussed in these pages and gauge their current…

Filed under:EMRsInsuranceOpinionPractice SupportRheuminationsSpeak Out RheumWorkforce Tagged with:burnoutCareercostsdrugEHRElectronic health recordsHealthcareinsurancepharmacy benefit managersphysicianPractice Managementrheumatologist

Obamacare Benchmark Premiums Up 37% in 2018 after Subsidy Cut-Off

Michael Erman  |  October 30, 2017

NEW YORK (Reuters)—The average monthly premium for benchmark Obamacare insurance plans will surge around 37% in 2018, the U.S. Department of Health and Human Services said on Monday, fueled by the Trump administration’s suspension of billions of dollars in subsidy payments to health insurers. The average monthly premium for the second-lowest cost “silver” plan for…

Filed under:Legislation & AdvocacyProfessional Topics Tagged with:Health InsuranceObamacareObamacare enrollmentObamacare subsidiessubsidies cut offTrump health subsidies cut

Rhode Island Doctor Pleads Guilty to Opioid Kickback Scheme

Nate Raymond  |  October 26, 2017

BOSTON (Reuters)—A Rhode Island doctor pleaded guilty on Wednesday to charges he participated in a scheme to obtain kickbacks in exchange for writing prescriptions for an addictive fentanyl-based cancer pain drug produced by Insys Therapeutics Inc. The plea by Jerrold Rosenberg came amid ongoing investigations of Insys related to Subsys, an under-the-tongue spray that contains…

Filed under:EthicsLegal Updates Tagged with:Cancerfentanyl-based cancer pain drugguilty pleahealthcare fraudInsys Therapeutics IncJerrold Rosenbergnational opioid addiction epidemicopioid crisisopioid kickback schemeRhode Island doctor

  • « Previous Page
  • 1
  • …
  • 85
  • 86
  • 87
  • 88
  • 89
  • …
  • 117
  • Next Page »
  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences